There are 413 resources available
120TiP - Premenopausal Women with Breast Cancer Optimally Treated with OFS (PROOFS)
Presenter: Lotta Ada Fischer
Session: Poster viewing and lunch
121TiP - LESS: Single-arm study to de-escalate adjuvant endocrine therapy duration in post-menopausal women with HR+ HER2- early breast cancer at very low risk of metastasis
Presenter: Magali Lacroix-Triki
Session: Poster viewing and lunch
127P - Exploratory biomarker (BM) analyses from IMpassion050
Presenter: Hong Zhang
Session: Poster viewing and lunch
128P - Long-Term Outcomes of Neoadjuvant Immunotherapy plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: an Extracted Individual Patient Data and Trial-Level Meta-Analysis
Presenter: Mariana Gouveia
Session: Poster viewing and lunch
129P - Impact of TROP-2 and its cellular localization on prognosis of breast cancer in the GAIN cohort
Presenter: Christina Westhoff
Session: Poster viewing and lunch
130P - Palbociclib in combination with letrozole in HR+/HER2- residual disease after standard neoadjuvant chemotherapy: primary results of the SOLTI1710 PROMETEO II window of opportunity trial
Presenter: Sonia Pernas Simon
Session: Poster viewing and lunch
131P - Efficacy of neoadjuvant letrozole and palbociclib in HER2-low vs HER2 zero luminal breast cancer. An analysis of the Unicancer Neopal phase II study.
Presenter: Jean-Sebastien Frenel
Session: Poster viewing and lunch
132P - Neoadjuvant zanidatamab for stage I node negative HER2 positive breast cancer (BC)
Presenter: Vicente Valero
Session: Poster viewing and lunch
133P - Personalized circulating tumor DNA (ctDNA) during neoadjuvant therapy (NAT) to predict response in patients (pts) with early-stage breast cancer (eBC)
Presenter: Mridula George
Session: Poster viewing and lunch